Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will host a teleconference at 8:00 a.m. EDT (7:00 a.m. CDT) on Monday, June 6, 2011, to review data presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Company executives will provide an overview of data presented at the meeting on the oncology portfolio and address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at: or by dialing 913-312-0677, confirmation code: 2538916. A replay of the call will be available beginning at 11:00 a.m. EDT on June 6 through midnight EDT on June 20. The replay can be accessed at or by dialing 402-280-9013, confirmation code: 2538916.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit or follow us on Twitter at


Bristol-Myers Squibb Company
Jennifer Fron Mauer, 609-252-6579
[email protected]
John Elicker, 609-252-4611
[email protected]

KEYWORDS:   United States  North America  Illinois  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Clinical Trials  Oncology  Other Health